# The CAMPUS Project: Cholinergic Augmentation of Cognitive Deficits in Schizophrenia

> **NCT00206947** · PHASE2 · TERMINATED · sponsor: **Birte Glenthoj** · enrollment: 50 (estimated)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** donepezil (5-10 mg/day)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00206947
- **Lead sponsor:** Birte Glenthoj
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2002-12
- **Primary completion:** 2005-01
- **Final completion:** 2005-01
- **Target enrollment:** 50 (ESTIMATED)
- **Why stopped:** No more funding
- **Last updated:** 2011-09-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00206947

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00206947, "The CAMPUS Project: Cholinergic Augmentation of Cognitive Deficits in Schizophrenia". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00206947. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*